These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6362821)

  • 21. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
    Mansel RE; Fallowfield L; Kissin M; Goyal A; Newcombe RG; Dixon JM; Yiangou C; Horgan K; Bundred N; Monypenny I; England D; Sibbering M; Abdullah TI; Barr L; Chetty U; Sinnett DH; Fleissig A; Clarke D; Ell PJ
    J Natl Cancer Inst; 2006 May; 98(9):599-609. PubMed ID: 16670385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results.
    Cowher MS; Grobmyer SR; Lyons J; O'Rourke C; Baynes D; Crowe JP
    J Am Coll Surg; 2014 Apr; 218(4):819-24. PubMed ID: 24655877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients.
    Kobayashi R; Shiraishi K; Iwase S; Ohtomo K; Nakagawa K
    Breast Cancer; 2015 Nov; 22(6):657-63. PubMed ID: 24756246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of dissection of the axilla in modified radical mastectomy.
    Cáceres E; Lingan M; Delgado P
    Surg Gynecol Obstet; 1976 Sep; 143(3):395-7. PubMed ID: 959960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy.
    Moossdorff M; Nakhlis F; Hu J; Barry WT; Losk K; Haskett C; Smidt ML; King TA
    Ann Surg Oncol; 2018 Sep; 25(9):2612-2619. PubMed ID: 29855827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of the functional anatomy of lymphatic drainage to the axilla in early breast cancer: A cohort study of 933 cases.
    Dorogi B; Bukovszky B; Mátrai T; Sávolt Á; Polgár C; Kelemen P; Kovács T; Rényi-Vámos F; Ivády G; Kovács E; Téglás M; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2019 Feb; 45(2):103-109. PubMed ID: 30322669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extent of regional lymph node surgery and impact on outcomes in patients with early-stage breast cancer and limited axillary disease undergoing mastectomy.
    Picado O; Khazeni K; Allen C; Yakoub D; Avisar E; Kesmodel SB
    Breast Cancer Res Treat; 2018 Sep; 171(2):461-469. PubMed ID: 29869773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
    Henke G; Knauer M; Ribi K; Hayoz S; Gérard MA; Ruhstaller T; Zwahlen DR; Muenst S; Ackerknecht M; Hawle H; Fitzal F; Gnant M; Mátrai Z; Ballardini B; Gyr A; Kurzeder C; Weber WP
    Trials; 2018 Dec; 19(1):667. PubMed ID: 30514362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer.
    Beenken SW; Urist MM; Zhang Y; Desmond R; Krontiras H; Medina H; Bland KI
    Ann Surg; 2003 May; 237(5):732-8; discussion 738-9. PubMed ID: 12724640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Axillary node interventions in breast cancer: a systematic review.
    Rao R; Euhus D; Mayo HG; Balch C
    JAMA; 2013 Oct; 310(13):1385-94. PubMed ID: 24084924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early stage carcinoma of the female breast and axillary lymph node dissection.
    Goldenberg IS
    Surg Gynecol Obstet; 1977 Oct; 145(4):562-4. PubMed ID: 897979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of radiation in the treatment of breast cancer.
    Small W; Lurie RH
    Oncology (Williston Park); 2001 Apr; 15(4):469-76; discussion 476, 479-80, 482-4 passim. PubMed ID: 11346934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is modified radical mastectomy adequate for axillary lymph node dissection?
    Nemoto T; Dao TL
    Ann Surg; 1975 Dec; 182(6):722-3. PubMed ID: 1190875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
    Galimberti V; Cole BF; Viale G; Veronesi P; Vicini E; Intra M; Mazzarol G; Massarut S; Zgajnar J; Taffurelli M; Littlejohn D; Knauer M; Tondini C; Di Leo A; Colleoni M; Regan MM; Coates AS; Gelber RD; Goldhirsch A;
    Lancet Oncol; 2018 Oct; 19(10):1385-1393. PubMed ID: 30196031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National surgical breast project.
    Benfield JR
    Calif Med; 1973 Mar; 118(3):5-9. PubMed ID: 4689540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New trends in the treatment of breast cancer at the Cancer Institute of Milan.
    Veronesi U
    AJR Am J Roentgenol; 1977 Feb; 128(2):287-9. PubMed ID: 401616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of operable breast cancer: the surgeon's view.
    Urban JA
    Cancer; 1978 Oct; 42(4):2066-77. PubMed ID: 101302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
    Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E
    Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.